Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2004 by Bispebjerg Hospital.
Recruitment status was  Recruiting
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
First received: September 13, 2005
Last updated: July 23, 2007
Last verified: December 2004
The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.

Condition Intervention
Device: Pulsed dye laser
Device: Intense pulsed light

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness

Further study details as provided by Bispebjerg Hospital:

Study Start Date: February 2005
Estimated Study Completion Date: August 2005

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Inclusion Criteria:

  • 18 years or older
  • Skin types I, II, III
  • No previous laser or IPL treatment for the condition

Exclusion Criteria:

  • Younger than 18 years old
  • Skin types IV, V, or VI
  • Pregnant or lactating women
  • Previous laser or IPL treatment for the condition
  • Recent exposure to sun or sun-beds
  • Treatment with oral retinoid within 6 months
  • Tendency to produce hypertrophic scars or keloids
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00206921

Contact: Merete Hædersdal, MD, PhD, DrMedSci +45 35 31 60 02 mhaedersdal@dadlnet.dk

Bispebjerg Hospital Recruiting
Copenhagen, Copenhagen NV, Denmark, 2400
Contact: Merete Hædersdal, MD, PhD, DrMedSci    +4535316002    mhaedersdal@dadlnet.dk   
Sponsors and Collaborators
Bispebjerg Hospital
Principal Investigator: Merete Hædersdal, MD, PhD, DrMedSci Bispebjerg Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00206921     History of Changes
Other Study ID Numbers: KF-01-236/04 
Study First Received: September 13, 2005
Last Updated: July 23, 2007
Health Authority: Denmark: Ministry of Health

Keywords provided by Bispebjerg Hospital:
Skin redness

Additional relevant MeSH terms:
Cardiovascular Diseases
Skin Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 26, 2016